ARMISTICE CAPITAL LLC 13D and 13G filings for PTC Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:18 pm Sale | 2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT | ARMISTICE CAPITAL LLC | 6,378,000 8.270% | -856,898 (-11.84%) | Filing |
| 2024-11-14 5:22 pm Purchase | 2024-09-30 | 13G | PTC Therapeutics, Inc. PTCT | ARMISTICE CAPITAL LLC | 7,234,898 9.400% | 370,898 (+5.40%) | Filing |
| 2024-02-14 3:50 pm Purchase | 2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT | ARMISTICE CAPITAL LLC | 6,864,000 9.100% | 6,864,000 (New Position) | Filing |